HPV Self-sampling Cost Effectiveness Model
Details
- Value
- GBP 250,000
- Topic
- Research and development services and related consultancy services
- Published
- 15 July 2024
- Submission
- 18 August 2024
- Source
- uk:find_a_tender
Tender description
The Department of Health and Social Care has appointed an experienced supplier to undertake a piece of cost-effectiveness modelling to understand the conditions under which harms will outweigh benefits for the offer of HPV self-sampling in the UK. Lot 1: The HPV self-sampling ISE will offer a portion of women eligible for cervical screening in England the choice between a clinician taken sample and a self-sample for HPV.<br/>The UK NSC has appointed the University of Sydney to undertake a piece of cost-effectiveness modelling to understand the conditions under which harms will outweigh benefits for the offer of HPV self-sampling in the UK. This is particularly important given that testing for HPV on a vaginal/urine self-sample could be slightly less sensitive than a clinician taken cervical sample. Therefore, modelling is required to understand how the self-sampling offer under different uptake scenarios could impact on the number of screen-detected HPV and treated cervical lesion.<br/>Contract term: 18 months with the option to extend for a period of up to 6 months.<br/>Contract value (including extensions): £249,876 excluding VAT (£299,852 including VAT). Lot 1: The HPV self-sampling ISE will offer a portion of women eligible for cervical screening in England the choice between a clinician taken sample and a self-sample for HPV.<br/>The UK NSC has appointed the University of Sydney to undertake a piece of cost-effectiveness modelling to understand the conditions under which harms will outweigh benefits for the offer of HPV self-sampling in the UK. This is particularly important given that testing for HPV on a vaginal/urine self-sample could be slightly less sensitive than a clinician taken cervical sample. Therefore, modelling is required to understand how the self-sampling offer under different uptake scenarios could impact on the number of screen-detected HPV and treated cervical lesion.<br/>Contract term: 18 months with the option to extend for a period of up to 6 months.<br/>Contract value (including extensions): £249,876 excluding VAT (£299,852 including VAT).
Timeline
- Completed: Tender published15 July 2024Current notice
- Completed: Submission date18 August 2024
About the buyer
Department of Health and Social Care is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.
Relevant CPV codes
- 73000000 · Research and development services and related consultancy services
Decision makers
Connect with the people behind this procurement.
| Contact name | Job title | Phone number | Work email |
|---|---|---|---|
| Head of Procurement | +44 •••• •••••• | ••••••••@department-of-health-and-social-care.gov | |
| Commercial Director | +44 •••• •••••• | ••••••••@department-of-health-and-social-care.gov | |
| Procurement Manager | +44 •••• •••••• | ••••••••@department-of-health-and-social-care.gov | |
| Category Lead | +44 •••• •••••• | ••••••••@department-of-health-and-social-care.gov | |
| Senior Buyer | +44 •••• •••••• | ••••••••@department-of-health-and-social-care.gov | |
| Contracts Manager | +44 •••• •••••• | ••••••••@department-of-health-and-social-care.gov |
32 similar open tenders
See more open tenders related to HPV Self-sampling Cost Effectiveness Model.
- Open tender
Expert Partner Panel Procurement 2026
- Open tender
Management Consultancy Dynamic Market
- Open tender
Space Technology Solutions
Related buyers
Buyers similar to Department of Health and Social Care.
- 1,685£204.6bn
- 1,505£58.1bn
- 731£1.3bn
- 677£133.0bn
- 640£160.0bn
- 447£8.1bn
- 335£7.4bn
- 324£1.3bn
- 273£1.1bn
- 225£484.2m
Win more public sector contracts
Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.
